CurveBeam AI is at the forefront of developing and manufacturing CT devices, particularly specializing in natural bilateral weight bearing CT technology aimed at improving visual assessments for diagnosing, prognosing, and managing orthopaedic and bone health issues. The company's corporate headquarters is located in Melbourne, with an operational base in Hatfield, PA, USA. CurveBeam AI has successfully raised around A$85 million in capital and employs over 50 staff across its Australian and US locations, supported by 18 regional distributors. Their product range includes both weight bearing and non-weight bearing CT devices, known for their advanced 3D scanning capabilities that enhance clinical assessments.
The company is actively developing cloud-based AI modules to assist doctors in diagnosis and surgical planning, addressing multibillion-dollar market opportunities, particularly in the US. These markets include a A$10 billion sector for Point of Care CT Imaging equipment and a A$4.1 billion per annum market for bone health, focusing on fracture prevention. CurveBeam AI forecasts a revenue of A$11 million for FY23, indicating a growth of approximately 49%, with 170 devices already placed globally in renowned medical institutions such as UCLA, Duke, and Mayo Clinic. Furthermore, the company has established a co-marketing and distribution agreement with the Foot & Ankle division of Stryker Corporation, significantly boosting its market presence with 38 placements of its leading HiRise device across orthopaedic practices in the US, EU, Australia, and other regions.
